Target intelligence / Profile preview

Ribosomal protein S29 pseudogene 24 (RPS29P24)

Target: RPS29P24
Molecular classification: Other (pseudogene)

Overview

Ribosomal protein S29 pseudogene 24 (RPS29P24) is classified as a pseudogene, meaning it is a genomic sequence derived from the functional ribosomal protein S29 gene (RPS29) but is typically non-functional, lacking the ability to encode a protein product due to mutations or disruptions. RPS29P24 does not produce a functional protein and has no established cellular, clinical, biological, or disease role. It is not considered a therapeutic target, nor does it have known pharmacological or biomarker utility.

Other names: RPS29_18_1653RPS29P24

Beyond the preview

Go deeper on Ribosomal protein S29 pseudogene 24 (RPS29P24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S29 pseudogene 24 (RPS29P24).

Explore the full profile